CBL & Associates Properties, Inc. (CBL) Given Average Rating of “Sell” by Analysts

Share on StockTwits

Shares of CBL & Associates Properties, Inc. (NYSE:CBL) have been given an average rating of “Sell” by the ten research firms that are presently covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $2.50.

Several research firms have recently issued reports on CBL. ValuEngine downgraded shares of CBL & Associates Properties from a “sell” rating to a “strong sell” rating in a research note on Wednesday, May 1st. Zacks Investment Research downgraded shares of CBL & Associates Properties from a “hold” rating to a “sell” rating in a research note on Tuesday, January 29th. Stifel Nicolaus reaffirmed a “neutral” rating on shares of CBL & Associates Properties in a research note on Monday, February 11th. Wells Fargo & Co reaffirmed a “sell” rating on shares of CBL & Associates Properties in a research note on Tuesday, February 12th. Finally, Barclays reaffirmed a “hold” rating and set a $2.00 price target on shares of CBL & Associates Properties in a research note on Tuesday, April 16th.

A number of hedge funds and other institutional investors have recently made changes to their positions in CBL. Evergreen Capital Management LLC bought a new position in CBL & Associates Properties during the first quarter worth $30,000. Creative Planning bought a new position in CBL & Associates Properties during the first quarter worth $31,000. Coldstream Capital Management Inc. bought a new position in CBL & Associates Properties during the fourth quarter worth $34,000. HHM Wealth Advisors LLC bought a new position in CBL & Associates Properties during the first quarter worth $37,000. Finally, Mercer Global Advisors Inc. ADV bought a new position in CBL & Associates Properties during the first quarter worth $41,000. 78.11% of the stock is owned by institutional investors and hedge funds.

Shares of CBL stock traded down $0.04 during trading hours on Thursday, hitting $1.03. 122,552 shares of the company’s stock traded hands, compared to its average volume of 3,310,554. The company has a market capitalization of $190.82 million, a P/E ratio of 0.60, a PEG ratio of -0.22 and a beta of 1.25. CBL & Associates Properties has a 12 month low of $0.99 and a 12 month high of $6.26. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.36 and a current ratio of 0.36.

About CBL & Associates Properties

Headquartered in Chattanooga, TN, CBL Properties owns and manages a national portfolio of market-dominant properties located in dynamic and growing communities. CBL's portfolio is comprised of 114 properties totaling 71.1 million square feet across 26 states, including 71 high-quality enclosed, outlet and open-air retail centers and 11 properties managed for third parties.

Recommended Story: Outstanding Shares, Buying and Selling Stocks

Analyst Recommendations for CBL & Associates Properties (NYSE:CBL)

Receive News & Ratings for CBL & Associates Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBL & Associates Properties and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Comparing Natus Medical  & Cutera
Comparing Natus Medical & Cutera
MintCoin Price Tops $0.0001 on Top Exchanges
MintCoin Price Tops $0.0001 on Top Exchanges
Global Currency Reserve Price Down 25% This Week
Global Currency Reserve Price Down 25% This Week
Analysts Expect DiaMedica Therapeutics Inc  to Post -$0.19 EPS
Analysts Expect DiaMedica Therapeutics Inc to Post -$0.19 EPS
Cumberland Pharmaceuticals, Inc.  Given Consensus Rating of “Strong Buy” by Analysts
Cumberland Pharmaceuticals, Inc. Given Consensus Rating of “Strong Buy” by Analysts
Merculet  Price Reaches $0.0013 on Exchanges
Merculet Price Reaches $0.0013 on Exchanges


 
© 2006-2019 Zolmax.